4-thio-2-deoxycytidine, manufacture a batch of 10 MG strength capsules under GMP
Ended Awarded Last action
- Contract number
- HHSN26100012
- Awardee
-
Societal Cdmo San Diego, LLC UEI YRPTVKHDL7Z5 Part of Irisys, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $60,424
Award facts
- Opportunity
-
- N02CM5700205 Solicitation number
- Manufacture of Oral and Topical Dosage Forms Award Notice · Posted Jul 6, 2015
- Manufacture of Oral and Topical Dosage Forms Award Notice · Posted Jan 6, 2015
- Contract value 100% obligated
- $60,424.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Original award | $60,424 |
About this award
This is a federal contract award from the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Societal CDMO San Diego, LLC, doing business as Irisys Inc. The $60,424 cost-plus-fixed-fee contract is for the manufacture of a 10 mg strength capsule formulation of the drug 4-thio-2-deoxycytidine under Good Manufacturing Practices (GMP). This contract supports the NCI's efforts in the manufacture of oral and topical dosage forms for investigational new drugs and clinical trials. Societal CDMO San Diego, a self-certified small disadvantaged business, is a contract development and manufacturing organization (CDMO) that specializes in pharmaceutical product development, manufacturing, and testing for federal agencies. The company holds multiple Indefinite Delivery Vehicle (IDV) contracts, including a $45 million Drug Formulation and Manufacturing Contracts 2019 IDV with the NIH. This specific contract does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN26100012?
HHSN26100012 was awarded to Societal Cdmo San Diego, LLC by National Cancer Institute (National Institutes of Health) on June 10, 2016.
How much is contract HHSN26100012 worth?
The government has obligated $60,424 on HHSN26100012.
Is contract HHSN26100012 an order under another contract?
Yes. HHSN26100012 is a delivery order under HHSN261201500009I, an indefinite delivery contract.
Was contract HHSN26100012 competed?
The extent of competition for HHSN26100012 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award